Long-term allergen exposure can attenuate inflammation and revert airway hyperreactivity to normal responsiveness. A model of such reversal was established in which airway hyperreactivity and inflammation in OVA-sensitized and challenged mice were decreased after multiple daily airway challenges. This change in responsiveness and inflammation was associated with a transition from a Th2-to a Th1-cytokine-biased profile in BAL fluid. Cell transfer from long-term exposed mice into hyperreactive mice also restored normal airway responsiveness, establishing the mechanism underlying the reversal of the hyperreactivity as active suppression, but did not affect eosinophilic airway inflammation. Conversely, airway hyperreactivity, suppressed as a result of longterm allergen exposure, could be re-established by depleting γδ T cells, in particular Vγ4+ cells. Antigen-specific tolerance of αβ T cells or suppression by non-γδ T cells did not play a role in the reversal to normal airway responsiveness and γδ T cells did not play a role in the regulation of the allergic inflammatory response. These findings show that normal responsiveness in previously hyperreactive mice, achieved after long-term allergen challenge, is based on several and apparently independent regulatory mechanisms. One of these, focused on airway responsiveness, involves active suppression and requires γδ T cells.
Introduction
Eosinophilic airway inflammation, Th2 type cytokine production and airway hyperresponsiveness (AHR) are characteristics of the response of mice to allergen sensitization and challenge (1) (2) (3) (4) . These responses are typically induced by acute or shortterm allergen challenge of sensitized hosts. Airway responses and underlying regulatory mechanisms after chronic or long-term allergen challenge, which may be more applicable to the clinical situation, are less well-defined (5, 6) . In animal models, chronic allergen challenge induces suppression of the Th2 response to allergen and reduces airway responsiveness and airway inflammation (7, 8) . Reductions of late phase asthmatic responses to allergen after long-term allergen challenge has also been reported in a clinical study (9) .
During the past several years, the importance of T lymphocytes in the orchestration of immune responses and modulation of airway responsiveness and airway inflammation has been delineated. Whereas αβ T cells mediate airway inflammation and hyperresponsiveness (10, 11) , γδ T cells have been found to prevent the development of AHR following allergen challenge in sensitized animals (12) (13) (14) . The cytokines IL-4, IL-5, and IL-13, released from activated type 2 T-helper cells (Th2), are linked to increases in AHR, airway inflammation and mucus hyperproduction (15, 16) . Other cytokines such as IL-12 and IFNγ released from type 1 T-helper cells (Th1) are thought to inhibit AHR and airway inflammation induced by allergen challenge (17) (18) (19) (20) (21) .
that γδ T cells are also involved in the mechanisms that abrogate or reverse airway hyperreactivity and inflammation following long-term allergen challenge. In the present study, we established a model of repeated allergen exposure that results in normalization of airway responsiveness in previously hyperreactive, allergic mice. Airway inflammation as well as levels of IL-4 and IL-5 in the bronchoalveolar lavage (BAL) fluid are decreased, while levels of IFNγ, IL-12 and IL-10 are increased. Lung lymphocytes transferred from such mice into short-term sensitized and challenged hyperreactive mice suppressed airway hyperreactivity but not airway inflammation.
Pulmonary γδ T cells in such mice increased as airway responsiveness normalized, suggestive of a counter-regulatory response. Indeed, depletion of γδ T cells and in particular, one Vγ-defined subset, abolished the suppressive effect of long-term allergen exposure as indicated by the re-appearance of AHR, but without an increase in airway inflammation.
Materials and Methods

Animals
Female BALB/c mice were purchased from Jackson Laboratory (Bar Harbor, ME), and cared for at National Jewish Medical and Research Center (Denver, CO). All experiments were conducted under a protocol approved by the Institutional Animal Care and Use
Committee.
Sensitization and airway challenge
Mice were sensitized to chicken ovalbumin (OVA) (grade V; Sigma Chemical Co., St Louis, MO) by intraperitoneal injection of 20 µg OVA emulsified in 2.25 mg aluminum (Inject®Alum; Pierce, Rockford, IL) in a total volume of 100 µl on days 1 and 14. After sensitization, animals were challenged with nebulized OVA (1% in PBS), 20 minutes daily either on days 28, 29, and 30 (short-term challenge) or daily from day 28 to day 52 (long-term challenge). Airway responsiveness to aerosolized methacholine (MCh) was evaluated on day 32 (short-term challenge) or day 54 (long-term challenge). Control groups were either sensitized with OVA (IP) but challenged with PBS or were nonsensitized (Nv) but challenged with OVA (N). Experiments were designed so that the ages of all groups were the same at the time of analysis (Figure 1 ).
Assessment of airway responsiveness
Airway responsiveness to aerosolized MCh was measured based on previously described procedures (2, 22 
Inflammatory cells, IgE and cytokine levels in BAL fluid
Immediately after assessment of airway responsiveness to MCh provocation, lungs were lavaged through the tracheal cannula with 1 ml Hank's balanced salt solution (HBSS) at room temperature. Total cell numbers were counted (Coulter Counter; Coulter, Hialeah, FL). Cytospin slides (Shandon, Sewickley, PA) were stained with Leukostat (Fischer Diagnostics, Pittsburgh, PA) and differential cell counts were carried out on at least 300 cells according to standard morphologic criteria.
The levels of IL-4, IL-5, IL-10, IL-12 and IFNγ in BAL fluid and cell culture medium were measured by enzyme-linked immunosorbent assays (ELISA). The assays were performed according to the manufacturer's instructions (R&D Systems, Inc. Minneapolis, MN). Cytokine levels in BAL fluid were calculated by comparison with known cytokine standards with a detection limit of 4 pg/ml for each cytokine.
OVA-specific IgE levels were quantitated by ELISA as previously described using standards established in the laboratory (23) .
Histologic examination of lung tissue
Lungs were fixed by injection of 1 ml 10% formaldehyde through the tracheal cannula.
The trachea was sutured to keep the fixative inside the lungs and airways. The paraffin- 
Preparation of lung lymphocytes and adoptive transfer
Lymphocytes isolated from lung tissue were used for evaluation of lymphocyte composition in the lungs, for in vitro cell culture, and for adoptive lymphocyte transfer experiments. Lung digests were obtained as previously described (23) . Briefly, lungs were removed and cut into small pieces of 0.5 mm in diameter and digested in 5 ml digestion buffer (0.5 mg/ml collagenase, 10% FCS, 100 U/ml penicillin, and 100 mg/ml streptomycin) at 37°C for 60 min. T-lymphocytes isolated from the lungs of long-term challenged mice to short-term challenged mice by injection through the tail vein ( Figure 1 ).
Depletion of γδ γδ γδ γδ T-lymphocytes with antibodies against the TCR
To further define the modulation of AHR and airway inflammation by γδ T cells, we 
Statistical analyses
Data are expressed as means±SEM for each group. The Kruskal-Wallis test was used first to ascertain that significant variance existed among the groups studied. The MannWhitney U-test was then used to test statistical significance of the differences between two groups. A p-value of less than 0.05 was considered significant.
Results
Airway responsiveness is normalized after long-term, repetitive allergen challenge
We first compared airway responsiveness of sensitized mice following short-and longterm allergen challenge by measuring airway responsiveness, RL and Cdyn, to inhaled
MCh. Short-term allergen challenge significantly increased airway responsiveness in sensitized mice compared to controls ( Figure 2 ). However, sensitized mice that experienced long-term challenges no longer exhibited AHR; the levels of airway responsiveness were similar to controls ( Figure 2 ). These data implied that airway responsiveness following short-and long-term allergen challenges was regulated in distinct ways. The complete loss of AHR potentially reflected exhaustion of responsiveness or the emergence of an active counter-regulatory mechanism.
Airway inflammation and mucus production are reduced after long-term allergen challenge
Short-term allergen challenge induced a typical inflammatory response in the airways in sensitized mice with extensive inflammatory infiltrates around the airways and blood vessels, eosinophil infiltration in lung tissue and BAL fluid ( Figures 3 and 4) . By contrast, mice exposed to long-term allergen challenges had reduced inflammation around the airways ( Figure 3C ), and fewer eosinophils in lung tissue (eosinophils were reduced from 169±8/mm BM in short-term challenged mice to 76±5/mm BM in longterm challenged mice) and BAL fluid but more lymphocytes in the BAL fluid compared to the short-term challenged mice ( Figure 4 ).
Short-term challenge also induced goblet cell hyperplasia and mucus production in the airways of sensitized mice compared to controls ( Figure 3 ). However, the number of goblet cells was significantly reduced from 9±0.4 cells per 100 µm basement membrane in short-term challenged mice to 5±0.5 after long-term challenge (n=12 in each group, p<0.05). The size of the goblet cells was also smaller after long-term challenge ( Figure   3C ).
Cytokine production and allergen-specific IgE are altered (Th2 to Th1) after longterm allergen exposure
Short-term challenge induced a Th2-type cytokine response in sensitized mice with elevated levels of IL-4 and IL-5 and decreased levels of IL-10 and IL-12 in the BAL fluid compared to controls that were only sensitized but not challenged (2IP). In contrast, in long-term challenged mice, the levels of IL-10, IL-12 and IFNγ were restored to levels seen in the sensitized but non-challenged mice. The level of IL-5 in long-term challenged mice was decreased compared to that in short-term challenged mice, but it remained significantly higher than in unchallenged controls ( Figure 5 ).
To confirm these findings at the cellular level, lung lymphocytes were isolated and cultured in vitro with OVA for 48 hours and the levels of IL-4 and IL-5 were measured by ELISA. The levels of IL-4 significantly increased from 147±15 pg/ml in controls to 368±55 pg/ml in short-term challenged mice and were decreased to 198±29 pg/ml in long-term challenged mice (n=8 in each group, p<0.05). The levels of IL-5 increased from 137±17 pg/ml in controls to 1018±159 pg/ml in short-term challenged mice and were reduced to 403±57 pg/ml in long-term challenged mice (n=8 in each group, p<0.05).
Following sensitization and 3 challenges, OVA-specific IgE levels rose from undetectable to 298±24 EU/ml. In long-term challenged mice, the levels of OVAspecific IgE were reduced to 102±18 EU/ml. Levels of OVA-specific IgG1 and IgG2a
showed little change.
Lung lymphocytes from long-term allergen exposed donors modulate airway responsiveness and cytokine production but not airway inflammation in hyperreactive recipients
As shown in Figure 4 , significantly increased numbers of lymphocytes in the BAL fluid were detected after long-term challenge, suggesting their role in the modulation of airway responses. To investigate this possibility, 5x10 6 lymphocytes (>93% CD3+, 59% CD4, 21% CD8, and 13% γδ) isolated from the lungs of long-term challenged mice were injected intravenously into sensitized mice before short-term challenge began. Airway responsiveness to MCh after short-term challenge was compared in the recipient mice.
AHR elicited by short-term challenge was totally abolished following adoptive transfer of lung lymphocytes from the long-term challenged mice ( Figure 6 ).
The levels of cytokines in the BAL fluid of short-term challenged mice were also altered following transfer of lung lymphocytes from long-term challenged mice. The levels of IL-5 were decreased and the levels of IL-10, IL-12 and IFNγ were increased after lymphocyte transfer ( Figure 5 ).
However, adoptive transfer of lung lymphocytes did not affect the inflammatory cell composition in BAL fluid in recipient, short-term challenged mice; that is, the predominant BAL fluid eosinophilic inflammatory response was sustained in the recipient mice (Figure 7) , and in the tissue (not shown). These data suggested that lung lymphocytes actively regulate airway responsiveness and cytokine production in the airways without altering eosinophilic airway inflammation.
γδ γδ γδ γδ T cells numbers are increased in the lung after long-term allergen challenge
We characterized the lymphocytes isolated from the lungs (following gradient centrifugation) with monoclonal antibody against CD3 and antibody GL-3 against TCR-δ. The percentage of CD3 + /γδ T cells in the lungs was assessed using flow cytometry.
The data showed that the percentage of CD3 + /γδ T cells in the lungs increased from 3% in non-challenged mice to 9% in short-term challenged mice and to 13% in long-term allergen challenged mice (p<0.05); CD3/CD8 T cells increased (15%, 17%, and 21% in non-challenged, short-and long-term challenged mice, respectively) while CD3/CD4 T cells decreased (68%, 63%, and 59% in non-challenged, short-and long-term challenged mice, respectively).
Depletion of γδ γδ γδ γδ T cells in long-term challenged mice restores AHR but not airway inflammation
To evaluate whether γδ T cells play a role in the reversal of AHR after long-term challenge, we depleted γδ T cells using monoclonal anti-TCR-δ antibodies (1:1 mixture of GL-3 and 403A-10). The mice were treated 7 days before airway responsiveness was significantly affect eosinophilic airway inflammation in the long-term challenged mice, which remained at low levels although increased over background levels ( Figure 11 ).
Discussion
Long-term allergen challenge can reduce allergic hyperresponsiveness in different species, including man (7-9), but the underlying mechanisms are not well-defined. In the current study, we established a model in which mice, hyperreactive to OVA as a result of prior sensitization and airway challenge, were restored to normal responsiveness following repeated challenge with aerosolized OVA. This model is characterized not only by a full reversal of airway hyperreactivity to inhaled MCh, but also a large reduction in eosinophilic airway inflammation, when compared to controls.
The return to normal airway responsiveness was associated with a change in cytokine profile in BAL fluid from a Th2-to a Th1-biased pattern, suggestive of active immunoregulation as opposed to an exhaustion of the host response. Consistently, pulmonary lymphocytes transferred from the long-term challenged mice suppressed airway responses in hyperreactive recipients ruling out passive mechanisms of nonresponsiveness as, for example, antigen-specific tolerance and depletion/anergy of OVAreactive αβ T cells (27) (28) (29) . Although these adoptive transfer experiments support an active suppression, in and of themselves, they do not directly implicate γδ T cells in the process. However, the transferred cells had no significant effect on eosinophilic airway inflammation in the allergic/hyperreactive recipients, suggesting that reduction of airway inflammation following long-term allergen challenge is governed by entirely different regulatory mechanisms.
In this model, we further found that γδ T cells are required for the inhibitory effect of long-term allergen exposure on AHR to MCh, but not for the reduction of eosinophilic airway inflammation. In fact, γδ T cells appeared solely responsible for the regulatory effect on AHR under these conditions, because their depletion fully restored hyperreactivity. On the other hand, there was no indication that γδ T cells played any part in the regulatory effects of long-term allergen exposure on eosinophilia in BAL fluid.
This comes as a surprise given that in infectious inflammation, a regulatory role for γδ T cells has been documented repeatedly (24, 30) . Perhaps, inflammation must be of a certain kind or mediated by a specific group of mediators, to be regulated by γδ T cells. In either case, these findings may help to explain conflicting observations with regard to the involvement of γδ T cells in different rodent models of asthma (12,31), as it appears that not all parameters examined are likely to reveal the influence of these cells. Finally, there was no indication that γδ T cells had an overall influence on the reversed Th cytokine shift (involving IL-4, IL-5 and IFNγ; Th2 to Th1) observed in long-term challenged mice. Direct regulatory effects on OVA-specific αβ T cells thus do not seem to play a role in this model of long-term allergen exposure. We previously showed that the regulatory effects of γ/δ T cells were exhibited in an α/β T-cell independent manner (12). On the other hand, γδ T cells were obviously required for the development of increased IL-10 and IL-12 levels after the long-term allergen challenge, suggestive of potential regulatory interactions with the innate system, including perhaps macrophages and dendritic cells, known to produce these cytokines in quantity (32) (33) (34) . Cumulatively, these findings may reflect a role for γδ T cells in an innate regulatory circuit capable of protecting normal airway responsiveness in the presence or absence of airway inflammation, as we have argued previously (12, 13), studying different models of AHR.
We have previously reported that AHR is increased in OVA-sensitized and challenged mice when γδ T cells are absent (12). Moreover, even in mice deficient in αβ T cells and thus incapable of developing an OVA-specific allergic response, we still found increased airway responses after OVA challenge when γδ T cells were absent (12). In both models, including adoptive transfer, Vγ4 + γδ T cells appear to be responsible for the protective effect (35, 36) , and in the current study, the same subset appears to mediate the suppressive effect of long-term allergen challenge on AHR. We have shown recently that the Vγ4 regulatory subset also expresses CD8β and produces IFNγ (35) . with aerosolized antibodies specific for Vγ4 resulted in AHR (35) . Therefore, the regulatory subset in the lung appears to be very small. This observation is reminiscent of a study published by McMenamin et al. (38) . who described the effects of repeated airway exposure to OVA in C57BL/6 mice. Very small numbers of splenic γδ T cells, isolated from these mice, suppressed primary IgE production in adoptive cell transfer recipients, and a similar finding was later reported with rats (39) . It seems likely that the mechanism of active suppression they described and that of active AHR suppression 2 I P 2 5 N 2 I P 2 5 N , a n t i -γ δ 2 I P 2 5 , a n t i -V γ 1 2 I P 2 5 , a n t i -V γ 4
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